RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA
Clinical trials for RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA trials appear
Sign up with your email to follow new studies for RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with deadly brain tumors: combination drug trial launches
Disease control Recruiting nowThis phase 2 trial is testing whether combining the drug ONC201 with other treatments (like paxalisib or a cancer-killing virus called DNX-2401) can help children and young adults with diffuse midline gliomas, a rare and aggressive brain cancer. The study enrolls 360 participants…
Matched conditions: RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New hope for kids with relapsed cancers: experimental drug CBL0137 enters trial
Disease control Recruiting nowThis study tests a new drug called CBL0137 in children and young adults (ages 1 to 21) whose solid tumors, brain tumors, or lymphoma have returned or stopped responding to treatment. The goal is to find the best dose, check side effects, and see if the drug can shrink tumors. The…
Matched conditions: RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE1, PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Promising targeted therapy for tough brain cancers moves forward
Disease control Recruiting nowThis study is testing a drug called Lutathera in children and young adults (ages 4 to 39) whose brain tumors have come back or are growing despite treatment. The drug delivers radiation directly to tumor cells that show up on a special PET scan. The goal is to find the safest dos…
Matched conditions: RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE1, PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC